XML 89 R44.htm IDEA: XBRL DOCUMENT v3.23.3
Revenue (Disaggregation of Revenue by Geographical Region) (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 29, 2023
Sep. 30, 2022
Sep. 29, 2023
Sep. 30, 2022
Dec. 31, 2022
Disaggregation of Revenue [Line Items]          
Revenue $ 6,873 $ 7,663 $ 21,197 $ 23,102  
Recurring revenue          
Disaggregation of Revenue [Line Items]          
Revenue 5,182 5,825 15,906 17,615  
Nonrecurring revenue          
Disaggregation of Revenue [Line Items]          
Revenue 1,691 1,838 5,291 5,487  
North America          
Disaggregation of Revenue [Line Items]          
Revenue 2,974 3,480 8,923 10,216  
Western Europe          
Disaggregation of Revenue [Line Items]          
Revenue 1,467 1,541 4,883 5,060  
Other developed markets          
Disaggregation of Revenue [Line Items]          
Revenue 330 339 1,010 1,063  
High-growth markets          
Disaggregation of Revenue [Line Items]          
Revenue 2,102 2,303 6,381 6,763  
Environmental & Applied Solutions          
Disaggregation of Revenue [Line Items]          
Revenue         $ 4,800
Operating segments | Biotechnology          
Disaggregation of Revenue [Line Items]          
Revenue 1,664 2,053 5,413 6,535  
Operating segments | Biotechnology | Recurring revenue          
Disaggregation of Revenue [Line Items]          
Revenue 1,390 1,662 4,435 5,267  
Operating segments | Biotechnology | Nonrecurring revenue          
Disaggregation of Revenue [Line Items]          
Revenue 274 391 978 1,268  
Operating segments | Biotechnology | North America          
Disaggregation of Revenue [Line Items]          
Revenue 593 723 1,822 2,303  
Operating segments | Biotechnology | Western Europe          
Disaggregation of Revenue [Line Items]          
Revenue 508 599 1,839 1,938  
Operating segments | Biotechnology | Other developed markets          
Disaggregation of Revenue [Line Items]          
Revenue 78 71 229 244  
Operating segments | Biotechnology | High-growth markets          
Disaggregation of Revenue [Line Items]          
Revenue 485 660 1,523 2,050  
Operating segments | Life Sciences          
Disaggregation of Revenue [Line Items]          
Revenue 1,706 1,723 5,211 5,090  
Operating segments | Life Sciences | Recurring revenue          
Disaggregation of Revenue [Line Items]          
Revenue 1,062 1,038 3,205 3,143  
Operating segments | Life Sciences | Nonrecurring revenue          
Disaggregation of Revenue [Line Items]          
Revenue 644 685 2,006 1,947  
Operating segments | Life Sciences | North America          
Disaggregation of Revenue [Line Items]          
Revenue 728 785 2,193 2,301  
Operating segments | Life Sciences | Western Europe          
Disaggregation of Revenue [Line Items]          
Revenue 356 314 1,095 982  
Operating segments | Life Sciences | Other developed markets          
Disaggregation of Revenue [Line Items]          
Revenue 117 118 369 366  
Operating segments | Life Sciences | High-growth markets          
Disaggregation of Revenue [Line Items]          
Revenue 505 506 1,554 1,441  
Operating segments | Diagnostics          
Disaggregation of Revenue [Line Items]          
Revenue 2,254 2,679 6,861 7,884  
Operating segments | Diagnostics | Recurring revenue          
Disaggregation of Revenue [Line Items]          
Revenue 1,986 2,396 6,056 7,067  
Operating segments | Diagnostics | Nonrecurring revenue          
Disaggregation of Revenue [Line Items]          
Revenue 268 283 805 817  
Operating segments | Diagnostics | North America          
Disaggregation of Revenue [Line Items]          
Revenue 1,054 1,397 3,160 3,938  
Operating segments | Diagnostics | Western Europe          
Disaggregation of Revenue [Line Items]          
Revenue 334 388 1,119 1,365  
Operating segments | Diagnostics | Other developed markets          
Disaggregation of Revenue [Line Items]          
Revenue 105 122 322 361  
Operating segments | Diagnostics | High-growth markets          
Disaggregation of Revenue [Line Items]          
Revenue 761 772 2,260 2,220  
Operating segments | Environmental & Applied Solutions          
Disaggregation of Revenue [Line Items]          
Revenue 1,249 1,208 3,712 3,593  
Operating segments | Environmental & Applied Solutions | Recurring revenue          
Disaggregation of Revenue [Line Items]          
Revenue 744 729 2,210 2,138  
Operating segments | Environmental & Applied Solutions | Nonrecurring revenue          
Disaggregation of Revenue [Line Items]          
Revenue 505 479 1,502 1,455  
Operating segments | Environmental & Applied Solutions | North America          
Disaggregation of Revenue [Line Items]          
Revenue 599 575 1,748 1,674  
Operating segments | Environmental & Applied Solutions | Western Europe          
Disaggregation of Revenue [Line Items]          
Revenue 269 240 830 775  
Operating segments | Environmental & Applied Solutions | Other developed markets          
Disaggregation of Revenue [Line Items]          
Revenue 30 28 90 92  
Operating segments | Environmental & Applied Solutions | High-growth markets          
Disaggregation of Revenue [Line Items]          
Revenue $ 351 $ 365 $ 1,044 $ 1,052